13 results on '"Salomaa, Sisko"'
Search Results
2. Application of radiation omics in the development of adverse outcome pathway networks: an example of radiation-induced cardiovascular disease.
- Author
-
Azimzadeh, Omid, Moertl, Simone, Ramadan, Raghda, Baselet, Bjorn, Laiakis, Evagelia C., Sebastian, Soji, Beaton, Danielle, Hartikainen, Jaana M., Kaiser, Jan Christian, Beheshti, Afshin, Salomaa, Sisko, Chauhan, Vinita, and Hamada, Nobuyuki
- Subjects
RADIOBIOLOGY ,ULTRAVIOLET radiation ,IONIZING radiation ,CARDIOVASCULAR diseases ,RADIATION ,BIOLOGICAL systems ,PREDICTIVE validity - Abstract
Epidemiological studies have indicated that exposure of the heart to doses of ionizing radiation as low as 0.5 Gy increases the risk of cardiac morbidity and mortality with a latency period of decades. The damaging effects of radiation to myocardial and endothelial structures and functions have been confirmed radiobiologically at high dose, but much less are known at low dose. Integration of radiation biology and epidemiology data is a recommended approach to improve the radiation risk assessment process. The adverse outcome pathway (AOP) framework offers a comprehensive tool to compile and translate mechanistic information into pathological endpoints which may be relevant for risk assessment at the different levels of a biological system. Omics technologies enable the generation of large volumes of biological data at various levels of complexity, from molecular pathways to functional organisms. Given the quality and quantity of available data across levels of biology, omics data can be attractive sources of information for use within the AOP framework. It is anticipated that radiation omics studies could improve our understanding of the molecular mechanisms behind the adverse effects of radiation on the cardiovascular system. In this review, we explored the available omics studies on radiation-induced cardiovascular disease (CVD) and their applicability to the proposed AOP for CVD. The results of 80 omics studies published on radiation-induced CVD over the past 20 years have been discussed in the context of the AOP of CVD proposed by Chauhan et al. Most of the available omics data on radiation-induced CVD are from proteomics, transcriptomics, and metabolomics, whereas few datasets were available from epigenomics and multi-omics. The omics data presented here show great promise in providing information for several key events (KEs) of the proposed AOP of CVD, particularly oxidative stress, alterations of energy metabolism, extracellular matrix (ECM), and vascular remodeling. The omics data presented here shows promise to inform the various levels of the proposed AOP of CVD. However, the data highlight the urgent need of designing omics studies to address the knowledge gap concerning different radiation scenarios, time after exposure, and experimental models. This review presents the evidence to build a qualitative omics-informed AOP and provides views on the potential benefits and challenges in using omics data to assess risk-related outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Introduction to the special issue on adverse outcome pathways in radiation protection.
- Author
-
Chauhan, Vinita, Azimzadeh, Omid, Salomaa, Sisko, and Hamada, Nobuyuki
- Subjects
RADIATION protection ,SCIENTIFIC knowledge ,RADIOBIOLOGY ,NUCLEAR energy ,IONIZING radiation - Abstract
This special issue of the International Journal of Radiation Biology entitled "Adverse Outcome Pathways in Radiation Protection" is inspired by growing global interest in approaches for integrating information from radiation biology and epidemiology to improve scientific understanding of low dose radiation health risk assessment. Also explored is benchmark dose modeling as a means to identify a point of departure (POD) for adverse phenotypic effects using transcriptional dose-response data (Chauhan et al. [8]). However, before this goal is reached, some important questions need to be addressed as to how different types, doses and dose rates of radiation exposure can accurately inform AOP development and how AOPs can reflect the latency of adverse health outcomes in a simplified form. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
4. Expert consultation is vital for adverse outcome pathway development: a case example of cardiovascular effects of ionizing radiation.
- Author
-
Chauhan, Vinita, Hamada, Nobuyuki, Monceau, Virginie, Ebrahimian, Teni, Adam, Nadine, Wilkins, Ruth C., Sebastian, Soji, Patel, Zarana S., Huff, Janice L., Simonetto, Cristoforo, Iwasaki, Toshiyasu, Kaiser, Jan Christian, Salomaa, Sisko, Moertl, Simone, and Azimzadeh, Omid
- Subjects
IONIZING radiation ,CARDIOVASCULAR system ,CARDIOVASCULAR diseases ,RADIATION exposure ,ENDOTHELIUM diseases ,OXIDATIVE stress ,RADIOECOLOGY - Abstract
The circulatory system distributes nutrients, signaling molecules, and immune cells to vital organs and soft tissues. Epidemiological, animal, and in vitro cellular mechanistic studies have highlighted that exposure to ionizing radiation (IR) can induce molecular changes in cellular and subcellular milieus leading to long-term health impacts, particularly on the circulatory system. Although the mechanisms for the pathologies are not fully elucidated, endothelial dysfunction is proven to be a critical event via radiation-induced oxidative stress mediators. To delineate connectivities of events specifically to cardiovascular disease (CVD) initiation and progression, the adverse outcome pathway (AOP) approach was used with consultation from field experts. AOPs are a means to organize information around a disease of interest to a regulatory question. An AOP begins with a molecular initiating event and ends in an adverse outcome via sequential linkages of key event relationships that are supported by evidence in the form of the modified Bradford-Hill criteria. Detailed guidelines on building AOPs are provided by the Organisation for Economic Cooperation and Development (OECD) AOP program. Here, we report on the questions and discussions needed to develop an AOP for CVD resulting from IR exposure. A recent workshop jointly organized by the MELODI (Multidisciplinary European Low Dose Initiative) and the ALLIANCE (European Radioecology Alliance) associations brought together experts from the OECD to present the AOP approach and tools with examples from the toxicology field. As part of this workshop, four working groups were formed to discuss the identification of adverse outcomes relevant to radiation exposures and development of potential AOPs, one of which was focused on IR-induced cardiovascular effects. Each working group comprised subject matter experts and radiation researchers interested in the specific disease area and included an AOP coach. The CVD working group identified the critical questions of interest for AOP development, including the exposure scenario that would inform the evidence, the mechanisms of toxicity, the initiating event, intermediate key events/relationships, and the type of data currently available. This commentary describes the four-day discussion of the CVD working group, its outcomes, and demonstrates how collaboration and expert consultation is vital to informing AOP construction. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Is there any supportive evidence for low dose radiotherapy for COVID-19 pneumonia?
- Author
-
Salomaa, Sisko, Bouffler, Simon D., Atkinson, Michael J., Cardis, Elisabeth, and Hamada, Nobuyuki
- Subjects
- *
COVID-19 , *OSTEOARTHRITIS , *PNEUMONIA , *IONIZING radiation , *RADIATION protection - Abstract
Since early April 2020, there has been intense debate over proposed clinical use of ionizing radiation to treat life-threatening pneumonia in Coronavirus Disease 2019 (COVID-19) patients. At least twelve relevant papers appeared by 20 May 2020. The radiation dose proposed for clinical trials are a single dose (0.1–1 Gy) or two doses (a few mGy followed by 0.1–0.25 Gy involving a putative adaptive response, or 1–1.5 Gy in two fractions 2–3 days apart). The scientific rationale for such proposed so-called low dose radiotherapy (LDRT) is twofold (note that only doses below 0.1 Gy are considered as low doses in the field of radiation protection, but here we follow the term as conventionally used in the field of radiation oncology). Firstly, the potentially positive observations in human case series and biological studies in rodent models on viral or bacterial pneumonia that were conducted in the pre-antibiotic era. Secondly, the potential anti-inflammatory properties of LDRT, which have been seen when LDRT is applied locally to subacute degenerative joint diseases, mainly in Germany. However, the human and animal studies cited as supportive evidence have significant limitations, and whether LDRT produces anti-inflammatory effects in the inflamed lung or exacerbates ongoing COVID-19 damage remains unclear. Therefore, we conclude that the available scientific evidence does not justify clinical trials of LDRT for COVID-19 pneumonia, with unknown benefit and known mortality risks from radiogenic cancer and circulatory disease. Despite the significant uncertainties in these proposals, some clinical trials are ongoing and planned. This paper gives an overview of current situations surrounding LDRT for COVID-19 pneumonia. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
6. Mitochondrial DNA damage in the hair bulb: can it be used as a noninvasive biomarker of local exposure to low LET ionizing radiation?
- Author
-
Hargitai, Rita, Roivainen, Päivi, Kis, Dávid, Luukkonen, Jukka, Sáfrány, Géza, Seppälä, Jan, Szatmári, Tünde, Virén, Tuomas, Vuolukka, Kristiina, Salomaa, Sisko, and Lumniczky, Katalin
- Subjects
IONIZING radiation ,MITOCHONDRIAL DNA ,DNA damage ,HAIR ,PROSTATE cancer patients - Abstract
Purpose: Our aim was to evaluate whether mitochondrial DNA (mtDNA) damage in hair bulbs could be a suitable biomarker for the detection of local exposure to ionizing radiation. Materials and methods: Mouse hair was collected 4 and 24 hours, 3 and 10 days after single whole-body exposure to 0, 0.1, and 2 Gy radiation. Pubic hair (treated area) and scalp hair (control area) were collected from 13 prostate cancer patients before and after fractioned radiotherapy with an average total dose of 2.7 Gy to follicles after five fractions. Unspecified lesion frequency of mtDNA was analyzed with long PCR, large mtDNA deletion levels were tested with real-time PCR. Results: Unspecified lesion frequency of mtDNA significantly increased in mouse hair 24 hours after irradiation with 2 Gy, but variance among samples was high. No increase in lesion frequency could be detected after 0.1 Gy irradiation. In prostate cancer patients, there was no significant change in either the unspecified lesion frequency or in the proportion of 4934-bp deleted mtDNA in pubic hair after radiotherapy. The proportions of murine 3860-bp common deletion, human 4977-bp common deletion and 7455-bp deleted mtDNA were too low to be analyzed reliably. Conclusions: Our results suggest that the unspecified lesion frequency and proportion of large deletions of mtDNA in hair bulbs are not suitable biomarkers of exposure to ionizing radiation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
7. Nuclear Weapons Tests and Human Germline Mutation Rate
- Author
-
Dubrova, Yuri E., Bersimbaev, Rakhmet I., Djansugurova, Leila B., Tankimanova, Maira K., Mustonen, Riitta, Lindholm, Carita, Hultén, Maj, and Salomaa, Sisko
- Published
- 2002
8. Funding for radiation research: past, present and future.
- Author
-
Cho, Kunwoo, Imaoka, Tatsuhiko, Klokov, Dmitry, Paunesku, Tatjana, Salomaa, Sisko, Birschwilks, Mandy, Bouffler, Simon, Brooks, Antone L., Hei, Tom K., Iwasaki, Toshiyasu, Ono, Tetsuya, Sakai, Kazuo, Wojcik, Andrzej, Woloschak, Gayle E., Yamada, Yutaka, and Hamada, Nobuyuki
- Subjects
IONIZING radiation ,RADIATION exposure ,RESEARCH funding ,TWENTIETH century ,FIELDWORK (Educational method) - Abstract
For more than a century, ionizing radiation has been indispensable mainly in medicine and industry. Radiation research is a multidisciplinary field that investigates radiation effects. Radiation research was very active in the mid- to late 20th century, but has then faced challenges, during which time funding has fluctuated widely. Here we review historical changes in funding situations in the field of radiation research, particularly in Canada, European Union countries, Japan, South Korea, and the US. We also provide a brief overview of the current situations in education and training in this field. A better understanding of the biological consequences of radiation exposure is becoming more important with increasing public concerns on radiation risks and other radiation literacy. Continued funding for radiation research is needed, and education and training in this field are also important. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
9. Toward tailoring radiation protection strategies at an individual level.
- Author
-
Hamada, Nobuyuki, Salomaa, Sisko, and Dörr, Wolfgang
- Subjects
- *
IONIZING radiation dosage , *RADIATION protection , *IONIZING radiation , *RADIOTHERAPY safety - Abstract
The article discusses the need for individualized radiation protection strategies due to differences in individual response to ionizing radiation (IR) exposures. Also cited are the works of the International Commission on Radiological Protection (ICRP) and the Multidisciplinary European Low Dose Initiative (MELODI) on Low Dose Effects on the issue, as well as such other topics as the tolerance dose concept in radiation therapy and the threshold dose concept in radiation protection.
- Published
- 2018
- Full Text
- View/download PDF
10. Roadmap for research on individual radiosensitivity and radiosusceptibility – the MELODI view on research needs.
- Author
-
Salomaa, Sisko and Jung, Thomas
- Subjects
- *
IONIZING radiation , *DATA security failures - Abstract
Roadmap for research on individual radiosensitivity and radiosusceptibility - the MELODI view on research needs The workshop covered three topics: (1) Clinical and epidemiological observations, (2) Mechanisms involved in individual radiation response, and (3) Tests for individual radiosensitivity/susceptibility to identify sensitive and susceptible subgroups both for cancer and non-cancer diseases. Patients with mutations in these response pathways have been identified and display a marked radiosensitivity but they represent only a small percentage of the radiotherapy (RT) patients with adverse reactions. Patients with mutations in the DNA damage response pathway display marked radiosensitivity but they represent only a small percentage of the RT patients with adverse reactions. [Extracted from the article]
- Published
- 2020
- Full Text
- View/download PDF
11. Non-targeted effects of ionising radiation—Implications for low dose risk
- Author
-
Kadhim, Munira, Salomaa, Sisko, Wright, Eric, Hildebrandt, Guido, Belyakov, Oleg V., Prise, Kevin M., and Little, Mark P.
- Subjects
- *
IONIZING radiation , *RADIATION doses , *GENE targeting , *RADIOBIOLOGY , *HEALTH risk assessment , *HOMEOSTASIS - Abstract
Abstract: Non-DNA targeted effects of ionising radiation, which include genomic instability, and a variety of bystander effects including abscopal effects and bystander mediated adaptive response, have raised concerns about the magnitude of low-dose radiation risk. Genomic instability, bystander effects and adaptive responses are powered by fundamental, but not clearly understood systems that maintain tissue homeostasis. Despite excellent research in this field by various groups, there are still gaps in our understanding of the likely mechanisms associated with non-DNA targeted effects, particularly with respect to systemic (human health) consequences at low and intermediate doses of ionising radiation. Other outstanding questions include links between the different non-targeted responses and the variations in response observed between individuals and cell lines, possibly a function of genetic background. Furthermore, it is still not known what the initial target and early interactions in cells are that give rise to non-targeted responses in neighbouring or descendant cells. This paper provides a commentary on the current state of the field as a result of the non-targeted effects of ionising radiation (NOTE) Integrated Project funded by the European Union. Here we critically examine the evidence for non-targeted effects, discuss apparently contradictory results and consider implications for low-dose radiation health effects. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
12. A laboratory inter-comparison of the importance of serum serotonin levels in the measurement of a range of radiation-induced bystander effects: Overview of study and results presentation.
- Author
-
Mothersill, Carmel, Antonelli, Francesca, Dahle, Jostein, Dini, Valentina, Hegyesi, Hargita, Iliakis, George, Kämäräinen, Kamy, Launonen, Virpi, Lumniczky, Katalin, Lyng, Fiona, Safrany, Géza, Salomaa, Sisko, Schilling-Tóth, Boglárka, Tabocchini, Antonella, and Kadhim, Munira A.
- Abstract
Purpose: Recent research has suggested that serotonin may play an important role in the expression of radiation-induced bystander effects. Serotonin levels in serum were reported to range from 6-22 μM and to correlate inversely with the magnitude of cellular colony-forming ability in medium transfer bystander assays. That is, high serotonin concentration correlated with a low cloning efficiency in cultures receiving medium derived from irradiated cells. Methods: Because of the potential importance of this observation, the European Union's Non-targeted Effects Integrated Project (NOTE) performed an inter-comparison exercise where serum samples with high and low serotonin levels were distributed to seven laboratories which then performed their own assay to determine the magnitude of the bystander effect. Results: The results provided some support for a role for serotonin in four of the laboratories. Two saw no difference between the samples and one gave inconclusive results. In this summary paper, full data sets are presented from laboratories whose data was inconclusive or insufficient for a full paper. Other data are published in full in the special issue. Conclusion: The data suggest that there may be multiple bystander effects and that the underlying mechanisms may be modulated by both the culture conditions and the intrinsic properties of the cells used in the assay. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
13. Ionizing radiation-induced circulatory and metabolic diseases.
- Author
-
Tapio, Soile, Little, Mark P., Kaiser, Jan Christian, Impens, Nathalie, Hamada, Nobuyuki, Georgakilas, Alexandros G., Simar, David, and Salomaa, Sisko
- Subjects
- *
METABOLIC disorders , *IONIZING radiation , *DISEASE risk factors , *OCCUPATIONAL exposure , *RADIATION protection , *DOSE-response relationship (Radiation) , *THRESHOLD limit values (Industrial toxicology) - Abstract
• Ionizing radiation causes adverse circulatory and metabolic effects at high doses. • Low-dose radiation is causally associated with circulatory disease. • Impact of low-dose radiation is modulated by inflammatory, stress, and immune responses. Risks to health are the prime consideration in all human situations of ionizing radiation exposure and therefore of relevance to radiation protection in all occupational, medical, and public exposure situations. Over the past few decades, advances in therapeutic strategies have led to significant improvements in cancer survival rates. However, a wide range of long-term complications have been reported in cancer survivors, in particular circulatory diseases and their major risk factors, metabolic diseases. However, at lower levels of exposure, the evidence is less clear. Under real-life exposure scenarios, including radiotherapy, radiation effects in the whole organism will be determined mainly by the response of normal tissues receiving relatively low doses, and will be mediated and moderated by systemic effects. Therefore, there is an urgent need for further research on the impact of low-dose radiation. In this article, we review radiation-associated risks of circulatory and metabolic diseases in clinical, occupational or environmental exposure situations, addressing epidemiological, biological, risk modelling, and systems biology aspects, highlight the gaps in knowledge and discuss future directions to address these gaps. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.